PAMELA HUMBER: Open Payments
NPI 1831534718 · GERMANTOWN, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$940 in 56 payments from 11 companies in 2025. Trend: 2023 $2,561 · 2024 $1,327 · 2025 $940
Food & beverage: $940
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 20 | $227 |
| Novo Nordisk Inc | 9 | $205 |
| AstraZeneca Pharmaceuticals LP | 7 | $140 |
| Actelion Pharmaceuticals US, Inc. | 6 | $111 |
| Alnylam Pharmaceuticals Inc. | 4 | $90 |
| Merck Sharp & Dohme LLC | 4 | $60 |
| VivaQuant Inc, dba Rhythm Express | 2 | $31 |
| Daiichi Sankyo Inc. | 1 | $24 |
| Abbott Laboratories | 1 | $20 |
| Elutia, Inc. | 1 | $17 |
Products named: LEQVIO, Wegovy, WAINUA, AMVUTTRA, UPTRAVI, OPSUMIT, Ozempic, VERQUVO.
Industry payments across TN — which companies pay providers there.
